quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:36:29·713d
NEWSRelease
Merrimack Pharmaceuticals Inc. logo

Merrimack Pharmaceuticals Announces Approval Of Plan Of Dissolution And Cash Liquidating Dividend Amount Of $15.10 Per Share

MACK· Merrimack Pharmaceuticals Inc.
Health Care
Original source

Companies

  • MACK
    Merrimack Pharmaceuticals Inc.
    Health Care

Related

  • SEC703d
    SEC Form 15-12G filed by Merrimack Pharmaceuticals Inc.
  • SEC708d
    SEC Form 10-Q filed by Merrimack Pharmaceuticals Inc.
  • PR710d
    Vicore Expands and Strengthens its Board of Directors
  • SEC713d
    SEC Form 25 filed by Merrimack Pharmaceuticals Inc.
  • SEC713d
    SEC Form 8-K filed by Merrimack Pharmaceuticals Inc.
  • PR713d
    Merrimack Pharmaceuticals, Inc. Announces Stockholder Approval of Plan of Dissolution And Cash Liquidating Dividend Amount of $15.10 Per Share of Common Stock
  • SEC715d
    SEC Form DEFA14A filed by Merrimack Pharmaceuticals Inc.
  • SEC715d
    SEC Form 8-K filed by Merrimack Pharmaceuticals Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022